{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022258","form_type":"8-K","ticker":"LFMD","cik":"0000948320","company_name":"LifeMD, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.755825+00:00","generated_at":"2026-05-17T21:17:22.189779+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeMD Q2 revenue up 23% to $62.2M, adjusted EBITDA up 223% to $7.1M; revises FY2025 guidance","bullets":["Total revenue $62.2M (+23% YoY), telehealth revenue $48.6M (+30%); telehealth adjusted EBITDA $3.4M (+560%).","Adjusted EBITDA $7.1M (+223% YoY); generated >$8M operating cash flow.","Paid down $2.1M senior debt, ended quarter with $36.2M cash; fully repaid all senior debt post-quarter.","Launched nationwide behavioral health offering, acquired virtual women's health brand, upgraded LifeMD+ membership.","Revised FY2025 guidance downward due to temporary challenges at Rex MD, still expects strong YoY growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022258","json":"https://secwatch.observer/filing/0001641172-25-022258.json","markdown":"https://secwatch.observer/filing/0001641172-25-022258.md","text":"https://secwatch.observer/filing/0001641172-25-022258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/948320/000164117225022258/0001641172-25-022258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/948320/000164117225022258/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:17:22.189779+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}